Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Defence Therapeutics Inc (DTCFF)

Defence Therapeutics Inc (DTCFF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Defence Therapeutics Announces AGM Results and Provides Corporate Updates Newsfile - Wed Dec 10, 3:36PM CST

Montreal, Quebec--(Newsfile Corp. - December 10, 2025) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTCQB: DTCFF) ("Defence" or the "Company"), a biotechnology company advancing a proprietary intracellular...

DTCFF : 0.4882 (-6.56%)
DTC.CN : 0.7000 (+1.45%)
Defence Therapeutics Announces Formation of Scientific Advisory Board to Guide Advancement of Accum-Enhanced Antibody Drug Conjugate Programs Newsfile - Thu Dec 4, 2:16AM CST

Montreal, Quebec--(Newsfile Corp. - December 4, 2025) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTCQB: DTCFF) ("Defence" or the "Company"), a biotechnology company advancing a proprietary intracellular...

DTCFF : 0.4882 (-6.56%)
DTC.CN : 0.7000 (+1.45%)
Defence Therapeutics Announces Convertible Debenture Conversion Newsfile - Fri Nov 21, 5:12PM CST

Montreal, Quebec--(Newsfile Corp. - November 21, 2025) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTCQB: DTCFF) ("Defence" or the "Company"), a leading biotechnology company pioneering next-generation...

DTCFF : 0.4882 (-6.56%)
DTC.CN : 0.7000 (+1.45%)
Defence Therapeutics to Build ADC Drug Delivery Powerhouse Using Its Proprietary Accum Technology Newsfile - Wed Nov 19, 2:16AM CST

Montreal, Quebec--(Newsfile Corp. - November 19, 2025) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTCQB: DTCFF) ("Defence" or the "Company"), a leading biotechnology company pioneering next-generation...

DTCFF : 0.4882 (-6.56%)
DTC.CN : 0.7000 (+1.45%)
Defence Announces Successful Presentation at the World ADC Conference in San Diego and Plans to Expand Evaluation of Accum in Commercial and Pipeline ADCs Newsfile - Thu Nov 6, 2:30AM CST

Montreal, Quebec--(Newsfile Corp. - November 6, 2025) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTCQB: DTCFF) ("Defence" or the "Company"), a leading biotechnology company pioneering next-generation...

DTCFF : 0.4882 (-6.56%)
DTC.CN : 0.7000 (+1.45%)
Defence Therapeutics Demonstrates Strong Preclinical in Vivo Efficacy Results Evaluating Accum-Kadcyla in Breast Cancer Models Newsfile - Tue Nov 4, 2:30AM CST

Montreal, Quebec--(Newsfile Corp. - November 4, 2025) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTCQB: DTCFF) ("Defence" or the "Company"), a leading biotechnology company specialized in drug...

DTCFF : 0.4882 (-6.56%)
DTC.CN : 0.7000 (+1.45%)
Defence to Present New Scientific Data on Its ADC-Enhancing Accum Technology at the World ADC Conference in San Diego, USA, November 4-5, 2025 Newsfile - Thu Oct 23, 2:22AM CDT

Montreal, Quebec--(Newsfile Corp. - October 23, 2025) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTCQB: DTCFF) ("Defence" or the "Company"), a leading biotechnology company specialized in drug...

DTCFF : 0.4882 (-6.56%)
DTC.CN : 0.7000 (+1.45%)
Defence Therapeutics to Engage with Global Pharma Leaders at CPHI Worldwide 2025 Tipranks - Tue Oct 7, 6:56AM CDT

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Defence Therapeutics...

DTCFF : 0.4882 (-6.56%)
Defence Therapeutics to Attend CPHI Worldwide in Frankfurt, October 28-30, 2025 Newsfile - Mon Oct 6, 2:18AM CDT

Montreal, Quebec--(Newsfile Corp. - October 6, 2025) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTCQB: DTCFF) ("Defence" or the "Company"), a leading biotechnology company specialized in drug...

DTCFF : 0.4882 (-6.56%)
DTC.CN : 0.7000 (+1.45%)
Defence Therapeutics Strengthens Leadership with New Head of Quality and Operations Tipranks - Fri Oct 3, 6:54AM CDT

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. An announcement...

DTCFF : 0.4882 (-6.56%)

Barchart Exclusives

5 "Best of the Best" Dividend Stocks to Own in 2026 Barchart - Fri Dec 19, 6:00PM CST
These five companies come with above-average yields and buy ratings from Wall Street analysts. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot